The European Commission issued hundreds of millions of dollars on pharmaceutical makers including France’s Servier for pay-for-delay deals that were found to have distorted the market, according to reports.
Servier and five generic drug makers were fined a combined $580 million for colluding to prevent generic and cheaper forms of medication …read more
Source: Global Competition Law Blogs